• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Our Bureau

HYDERABAD, July 8

OCIMUM Biosolutions Ltd (OBL), the Hyderabad-based Indian arm of the US-based Ocimum Biosolutions, has entered into collaboration with the New York-based Hospital for Joint Diseases Orthopaedic Institute (HJD).

In a press release, the company said the collaboration was for analysing HJD's musculoskeletal diseases data using the Ocimum's micro array analysis tool Genowiz.

HJD is a voluntary and not-for-profit speciality medical hospital with expertise in orthopaedic surgery, rheumatology and molecular medicine, rehabilitation medicine and neurology.Genowiz is a gene expression analysis and tracking tool that enables researchers to analyse micro array data in an intuitive and comprehensive bio-environment.

Commenting on the collaboration, the Ocimum Chief Executive Officer, Ms Anuradha Acharya, said: "This partnership will enhance our capabilities in analysing expression data and fine-tuning our product, Genowiz. "

Article E-Mail :: Comment :: Syndication

Stories in this Section
Arisaig offloads Apollo Hospitals equity shares

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line